...
首页> 外文期刊>Advances in Infectious Diseases >Fatal Pulmonary Mycobacterium Celatum Infection in an Immunocompetent Patient. An Eight-Year Follow-Up of the First Case, a Review of the Literature and a Report of Beta-2 Microglobulin as a Potential Indicator of Disease Severity
【24h】

Fatal Pulmonary Mycobacterium Celatum Infection in an Immunocompetent Patient. An Eight-Year Follow-Up of the First Case, a Review of the Literature and a Report of Beta-2 Microglobulin as a Potential Indicator of Disease Severity

机译:具有免疫功能的患者的致命性肺分枝杆菌Celatum感染。第一个病例的八年随访,文献复习和报告β-2微球蛋白作为疾病严重程度的潜在指标

获取原文
           

摘要

Setting: Swedish county hospital. Objective: Pulmonary M. celatum infection has been previously described only twice in an immunocompetent individual with no pre-existing chest disease. We describe the first Swedish case report of unusual drug-related complications and review the literature. Discussion: Atypical mycobacteriosis is often difficult to treat. We describe a fatal case of m celatum pneumonia in a previously healthy patient, unusual side effects encountered during her treatment and also the report of the utility of beta-2-microglobulin as a way to measure disease activity in mycobacterial infections. Conclusions: M. celatum may cause fatal pneumonia in previously healthy individuals. Treating the disease may be fraught with difficulty and there is a risk for very severe side effects, all of which must be weighed before taking the decision to treat this disease. ?
机译:地点:瑞典县医院。目的:以前,在没有早发性胸病的具有免疫能力的个体中,肺部支原体感染仅被描述过两次。我们描述了首例罕见的药物相关并发症的瑞典病例报告,并复习了文献。讨论:非典型分枝杆菌病通常很难治疗。我们描述了一名先前健康患者的致命性肺炎性肺炎病例,在她的治疗期间遇到了不寻常的副作用,还报道了β-2-微球蛋白作为一种测量分枝杆菌感染中疾病活动性的方法的报道。结论:C。celatum可能在先前健康的个体中引起致命性肺炎。治疗该疾病可能充满困难,并且存在非常严重的副作用的风险,在决定治疗该疾病之前必须权衡所有这些副作用。 ?

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号